Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson’s Disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-1182
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson’s Disease ; day:10 ; month:10 ; year:2017 ; pages:1-19
Molecular neurobiology ; (10.10.2017), 1-19
- Schlagwort
-
Fitness
Sportunterricht
Fitnesstraining
Sportpädagogik
Präventives Training
Gesundheitssport
- Urheber
-
Klemann, Cornelius J. H. M.
- Beteiligte Personen und Organisationen
-
Xicoy, Helena
Poelmans, Geert
Bloem, Bas R.
Martens, Gerard J. M.
Visser, Jasper E.
SpringerLink (Online service)
- DOI
-
10.1007/s12035-017-0775-0
- URN
-
urn:nbn:de:1111-2017111513521
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.03.2026, 06:38 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Klemann, Cornelius J. H. M.
- Xicoy, Helena
- Poelmans, Geert
- Bloem, Bas R.
- Martens, Gerard J. M.
- Visser, Jasper E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson’s disease treated with L-DOPA
Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
CYP2E1 and Parkinson’s disease in a MPTP-induced C57BL/6 mouse model
MPTP and the aetiology of Parkinson's disease : clinical implications
L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin
DOPA-sparing strategy in the treatment of young onset Parkinson’s disease
Dopa-Pause während der Langzeitbehandlung von Parkinson-Kranken
Neuroprotection and neurorestoration in the MPTP model for Parkinson's disease
Regulation des Autophagieproteins ULK1 im MPTP-Mausmodell des Morbus Parkinson
MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson’s Disease
L-Dopa-Substitution der Parkinson-Krankheit : Geschichte - Gegenwart - Zukunft
Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson’s disease treated with L-DOPA
Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
CYP2E1 and Parkinson’s disease in a MPTP-induced C57BL/6 mouse model
MPTP and the aetiology of Parkinson's disease : clinical implications
L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin
DOPA-sparing strategy in the treatment of young onset Parkinson’s disease
Dopa-Pause während der Langzeitbehandlung von Parkinson-Kranken
Neuroprotection and neurorestoration in the MPTP model for Parkinson's disease
Regulation des Autophagieproteins ULK1 im MPTP-Mausmodell des Morbus Parkinson
MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson’s Disease
L-Dopa-Substitution der Parkinson-Krankheit : Geschichte - Gegenwart - Zukunft
Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson’s disease treated with L-DOPA
Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
CYP2E1 and Parkinson’s disease in a MPTP-induced C57BL/6 mouse model
MPTP and the aetiology of Parkinson's disease : clinical implications
L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin
DOPA-sparing strategy in the treatment of young onset Parkinson’s disease
Dopa-Pause während der Langzeitbehandlung von Parkinson-Kranken
Neuroprotection and neurorestoration in the MPTP model for Parkinson's disease
Regulation des Autophagieproteins ULK1 im MPTP-Mausmodell des Morbus Parkinson
MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson’s Disease